Fairscale Capital’s Organon & Co OGN Stock Holding History

Fairscale Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379	Hold	28	–	–	﹤0.01%	428
2026 Q1	$168	Hold	28	–	–	﹤0.01%	431
2025 Q4	$201	Sell	28 -18	-39%	-$142	﹤0.01%	420
2025 Q3	$491	Hold	46	–	–	﹤0.01%	430
2025 Q2	$446	Hold	46	–	–	﹤0.01%	429
2025 Q1	$685	Hold	46	–	–	﹤0.01%	332
2024 Q4	$686	Hold	46	–	–	﹤0.01%	338
2024 Q3	$880	Hold	46	–	–	﹤0.01%	328
2024 Q2	$957	Buy	+46	New	+$914	﹤0.01%	334

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Fairscale Capital's OGN Position: Q2 2026 in Review

Fairscale Capital held its Organon & Co (OGN) position steady in Q2 2026 at 28 shares worth $379. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Fairscale Capital first reported a position in OGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $957 in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Fairscale Capital held 28 shares of Organon & Co worth $379 as of Q2 2026.
Fairscale Capital left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Fairscale Capital's portfolio in Q2 2026, its #428 holding.
Fairscale Capital first reported a position in Organon & Co in Q2 2024 and has held it in 9 quarters since.
Fairscale Capital's Organon & Co position peaked at $957 in Q2 2024.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.